Full Single-Cell Technology 2022: 10x Genomics, Fluidigm, BD Biosciences and Berkeley Light Lead the Way in a Rapidly Growing Industry – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Comprehensive Single Cell Technology 2022” report has been added to from ResearchAndMarkets.com offer.

The global Single Cell Technology (SCT) market has emerged since the mid-2010s. SCT is defined as any cell biology research tool that provides single cell resolution processing and datasets, e.g. single cell (SC) collection/distribution, SC sequencing and SC protein analysis technologies. There are more than 58 commercial SCT products from 52 companies and more than 30 pre-commercial stage startups that will enter the market in the next few years. The SCT market is above all young and complex: more than 75% of products have been launched in the last 7 years. More than 70% of market players are startups less than 10 years old. It is also characterized by its wide range of technology combinations and its different types of users. The market size is around USD 0.86 billion in 2021, with a CAGR of around 28% when calculated based on the top 38 companies only.

The market share is heavily concentrated on the big four 10x Genomics, Fluidigm, BD Biosciences, and Berkeley Light, but this market share may change as the market grows with more players. Here we have identified commercial SCT products and segmented by technical principles (sampling, dispensing, droplet-based, microwell-based, etc.) and by the five application or functionality spectra: SC- l isolation, SC-distribution (cell lineage development), SC (or multi-omics) sequencing, SC protein analysis and new cell characterization. We also take a look at the 37 early-stage startups, including 18 space biology companies/products. For each startup, we present the company profile, technology description and target market applications. The report also features label-free live cell imaging, microfluidic chip-based flow cytometry, and small liquid delivery technologies. In total, we are introducing over 100 new technologies/companies around single cell resolution bioresearch tools.

Answers to key questions:

  • What is the complete list of commercial SCT technologies, including all start-ups?

  • Who are emerging SCT startups?

  • What is Single Cell Technology (SCT) and its history?

  • What are the main technical principle and applications?

  • What are their competitive advantages and their main differentiators?

  • What is the current market size, commercial capacity and growth potentials (revenues, installed bases, prices)? – What are the research objectives, trends, user needs and challenges?

  • What area of ​​research is actively using SCT?

  • What are the important features of popular applications such as cell line development, antibody discovery, and SC genomics?

Main topics covered:

Introduction

  • Report objectives

  • Main characteristics

  • Methodology-How the report was written

Part 1. Global Single Cell Technology (SCT) Market Overview

1.1 What is TBS and why single cell

1.2 History of TBS

1.3 Market Player Analysis (Timetable, Location, Number of Employees)

1.4 Market Segmentation by Single Cell Handling Technical Principle

Complete list of companies and products

1.5 Market Segmentation by Major Application/Functions

Complete list of companies and products

1.6 Market Size and Market Share by Revenue

1.7 Current Market Trends and Challenges

Part 2. Current SCT Commercial Products

2.1 Image-based single-cell capture technologies

2.2 Single-cell distribution technologies

2.3 Genomics/transcriptomics/multi-omics technologies

2.4 Proteomics or protein level analysis technologies

2.5 New cell characterization technologies

Part 3. Identification of emerging startups

3.1 Single cell isolation – 3 companies

Complete List of 21 SC Insulation Companies in the Market

3.2 Single cell sequencing – 4 companies

3.3 Single cell-multi-omics (SC-seq/proteins/imaging/phenomics)

3.4 Data analysis – 3 companies

3.5 Screening – 3 companies

3.6 New cell sorter – 5 companies

3.7 Others – 4 companies

3.8 Space biology – 11 companies + 7 commercial companies

3.9 Early Stage Startups Analysis

Part 4. Special Features

4.1 Label-Free Live Cell Imaging Technologies

4.2 Flow cytometry technologies on a microfluidic chip

4.3 Robotic Liquid Handling Technologies

For more information about this report visit https://www.researchandmarkets.com/r/a2b2l6

Comments are closed.